Whole blood rotation thromboelastometry (ROTEM ®) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V

Haemophilia

Volumn 18, Issue 3, 2012, Pages 463-468

  Spiezia, L ^a   Radu, C ^a   Campello, E ^a   Bulato, C ^a   Bertini, D ^a   Barillari, G ^b   De Angelis, V ^c   Pradella, P ^b   Zanon, E ^a   Simioni, P ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

^c UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

Author keywords

Global tests; Plasma and intraplatelets FV; ROTEM; Severe FV deficiency; Thromboelastometry

Indexed keywords

BLOOD CLOTTING FACTOR 5; FRESH FROZEN PLASMA; THROMBIN; THROMBOCYTE FACTOR 5;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HEMOPHILIA; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LABORATORY DEVICE; MALE; PRIORITY JOURNAL; ROTATION THROMBOELASTOMETRY; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY;

ADULT; AREA UNDER CURVE; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; FACTOR V DEFICIENCY; FEMALE; HUMANS; MALE; MIDDLE AGED; THROMBELASTOGRAPHY;

EID: 84860343390     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02710.x     Document Type: Article

References (20)

1. Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem 1985; 260: 2119-24.
2. Monkovic DD, Tracy PB. Activation of human factor V by factor Xa and thrombin. Biochemistry 1990; 29: 1118-28.
3. Tracy PB, Eide LL, Bowie EJW, Mann KG. Radioimmunoassay of FV in human plasma and platelets. Blood 1982; 60: 59-63.
4. Owren PA. Parahemophilia, hemorrhagic diathesis due to the absence of a previously recognized clotting factor. Lancet 1977; 1: 446-8.
5. Lak M, Sharifian R, Peyvandi F, Mannucci PM. Symptoms of inherited factor V deficiency in 35 Iranian patients. Br J Haematol 1998; 103: 1067-9.
6. Peyvandi F, Mannucci PM. Rare coagulation disorders. Thromb Haemost 1999; 82: 1207-14.
7. Hvitfeldt PoulsenL, Christiansen K, Sørensen B, Ingerslev J. Whole blood thrombelastographic profiles using minimal tissue factor activation can display hypercoagulation in thrombosis-prone patients. Scand J Clin Lab Invest 2006; 66: 329-36.
8. Spiezia L, Marchioro P, Radu C et al. Whole blood coagulation assessment using rotation thrombelastogram thromboelastometry in patients with acute deep vein thrombosis. Blood Coagul Fibrinolysis 2008; 19: 355-60.
9. Ingerslev J, Hvitfeldt Poulsen L, Sørensen B. Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophilia. Haemophilia 2003; 9: 348-52.
10. Sørensen B, Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004; 2: 102-10.
11. Johansen RF, Sørensen B, Ingerslev J. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy. Haemophilia 2006; 12: 190-7.
12. Duckers C, Simioni P, Spiezia L et al. Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency. Blood 2008; 112: 3615-23.
13. Rodeghiero F, Tosetto A, Castaman G. How to estimate bleeding risk in mild bleeding disorders. J Thromb Haemost 2007; 5: 157-66.
14. Duckers C, Simioni P, Spiezia L et al. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms. Blood 2010; 115: 879-86.
15. Simioni P, Scudeller A, Radossi P et al "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. Thromb Haemost 1996; 75: 422-6.
16. Calatzis AN, Fritzsche P, Calatzis AL, Kling M, Hipp R, Stemberger A. A comparison of the technical principle of the roTEG coagulation analyser and conventional thrombelastographic system [abstract]. Ann Hematol 1996; 72(Sup I)P90: 142-6.
17. Spiezia L, Radu C, Marchioro P et al. Peculiar whole blood rotation thromboelastometry (Rotem) profile in 40 sideropenic anaemia patients. Thromb Haemost 2008; 100: 1106-10.
18. Nielsen VG, Geary BT, Baird MS. Evaluation of the contribution of platelets to clot strength by thromboelastography in rabbits: the role of tissue factor and cytochalasin D. Anesth Analg 2000; 91: 35-9.
19. Zuckerman L, Cohen E, Vagher JP, Woodward E, Caprini JA. Comparison of thrombelastography with common coagulation tests. Thromb Haemost 1981; 46: 752-6.
20. Castoldi E, Duckers C, Radu C et al. Homozygous F5 deep-intronic splicing mutation resulting in severe factor V deficiency and undetectable thrombin generation in platelet-rich plasma. J Thromb Haemost 2011; 9: 959-68.